We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
XTRA:RGO
logo

Regeneron Pharmaceuticals (RGO)

XTRA • RGO • US75886F1075

Ex-dividend 20 Nov · 0.94 USD (special)
851.50Last close
Market Closed
Ex-dividend 20 Nov · 0.94 USD (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 4, 2026, ORTEX estimated 0.1% of free float sold short, 911.7 days to cover, cost to borrow 0.19%. Sign up for live short interest data.

Market Cap

96.1b USD | # 227 in DE

Volume

63 shares | 59.65k USD

Shares Outstanding

98.53m

Free Float Shares

97.80% | 96.36m

Nasdaq:REGN|
DB:RGO|
LSE:0R2M|
BOVESPA:REGN34|
BIT:1REGN|
WBAG:REGN

News

RGO key data

Regeneron Pharmaceuticals (XTRA: RGO) has a market capitalization of $96.11B. Last close €851.50 (as of 2026-11-20); 52-week range €509.80 to €885.20. ORTEX data as of 2026-11-04: short interest was 0.07% of free float, 911.7 days to cover and the average cost to borrow was 0.19%. Sign up for live short interest data.

  • RGO news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.